UBS Group’s FTAC Hera Acquisition Corp. Warrant HERAW Stock Holding History

UBS Group’s Portfolio HERAW Stock Details HERAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,819	Closed	-$145	–	11332
2022 Q4	$145	Buy	4,819 +1,161	+32%	+$47	﹤0.01%	10355
2022 Q3	$0	Sell	3,658 -1,000	-21%	-$135	﹤0.01%	11459
2022 Q2	$1K	Sell	4,658 -6,200	-57%	-$1.84K	﹤0.01%	10129
2022 Q1	$5K	Buy	+10,858	New	+$6.16K	﹤0.01%	9226
2021 Q4	–	Sell	-1,284	Closed	-$1K	–	11063
2021 Q3	$1K	Buy	1,284 +794	+162%	+$937	﹤0.01%	9354
2021 Q2	$1K	Buy	+490	New	+$529	﹤0.01%	9256

UBS Group's HERAW Position: Q1 2023 in Review

UBS Group sold out of FTAC Hera Acquisition Corp. Warrant (HERAW) in Q1 2023, closing a stake of 4,819 shares — an estimated $145 sold.

UBS Group first reported a position in HERAW in Q2 2021 and held it in 6 quarters. The position peaked at $5K in Q1 2022. 0 funds tracked by Wall St. Rank hold HERAW as of Q1 2023.

UBS Group reported no remaining FTAC Hera Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
UBS Group sold 4,819 FTAC Hera Acquisition Corp. Warrant shares in Q1 2023, an estimated $145.
UBS Group first reported a position in FTAC Hera Acquisition Corp. Warrant in Q2 2021 and held it in 6 quarters.
UBS Group's FTAC Hera Acquisition Corp. Warrant position peaked at $5K in Q1 2022.
0 funds tracked by Wall St. Rank held FTAC Hera Acquisition Corp. Warrant as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.